Trends in transfusion rates after the FOCUS trial.
We estimate the impact of the FOCUS trial, which concluded that hip surgery patients with hemoglobin values above 8 g/dl do not benefit from routine transfusions, on transfusion rates. We evaluated trends in transfusion rates using inpatient discharge data from four states. The transfusion rate was 5.2 percentage points lower in the fourth quarter of 2013 than it would have been had pre-FOCUS trends continued. Transfusion rates declined more in hospitals with a low end-of-life treatment intensity index, a general measure of treatment intensity. The FOCUS trial affected practice, but there are additional opportunities to reduce the use of transfusions.